Body Image Disorder in Anorexia Nervosa and Virtual Reality

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03118921

Acronym

REVAM

Enrollment

Registered

2017-04-18

Start date

2017-04-20

Completion date

2019-10-31

Last updated

2021-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia

Brief summary

Evaluation of the tolerance and acceptability of the virtual representation of its body image.

Interventions

DEVICEVirtual reality

The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DEVICE_FEASIBILITY

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

16 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Women, aged between 16 and 40 * Post-puberty * Pure restrictive anorexia nervosa, diagnosis by the DSM-V * BMI \<17.5 * Patient attending an outpatient clinic at the Bohars Psychiatric Hospital in France * Having signed the Informed Consent Form * For minor patients, signing the form of informed consent of both parents

Exclusion criteria

* Associated eating disorder (bulimia, or the binge eating / purging form of anorexia nervosa), * Psychiatric disorders (characterized depressed, anxiety disorder) * Neurological Disorders * Mental retardation * Abuse or addiction to alcohol * Abuse or dependence on psychoactive substances in the previous year. * Patient with a protective justice measure

Design outcomes

Primary

Measure	Time frame	Description
Self-questionnaire assessing tolerance	Day 15	Patients will have to respond to a self-administered questionnaire assessing tolerance
Self-questionnaire assessing acceptability	Day 15	Patients will have to respond to a self-administered questionnaire assessing acceptability

Secondary

Measure	Time frame	Description
Feeling of presence	Day 15	Patients will respond to a self-questionnaire of feeling of presence
Subjective experience by EDI-2 questionnaire	Day 15	Pre- and post-test comparison of body dissatisfaction by EDI-2 questionnaire.
Subjective experience by BSQ questionnaire	Day 15	Pre- and post-test comparison of body dissatisfaction by BSQ questionnaire.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026